Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 360


A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.

Zhang Y, Sturgis EM, Wei P, Liu H, Wang Z, Ma Y, Liu C, Gu KJ, Wei Q, Li G.

Mol Carcinog. 2019 Sep 12. doi: 10.1002/mc.23116. [Epub ahead of print]


Knowledge matters and empowers: HPV vaccine advocacy among HPV-related cancer survivors.

Shelal Z, Cho D, Urbauer DL, Lu Q, Ma BY, Rohrer AM, Kurian S, Sturgis EM, Ramondetta LM.

Support Care Cancer. 2019 Sep 6. doi: 10.1007/s00520-019-05035-1. [Epub ahead of print]


Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy.

Bagley AF, Ye R, Garden AS, Gunn GB, Rosenthal DI, Fuller CD, Morrison WH, Phan J, Sturgis EM, Ferrarotto R, Wu R, Liu AY, Frank SJ.

Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33002-6. doi: 10.1016/j.radonc.2019.07.012. [Epub ahead of print]


Direct medical cost of oropharyngeal cancer among patients insured by Medicaid in Texas.

Zhao B, Fu S, Wu CF, Dahlstrom KR, Domgue JF, Tam S, Xu L, Sturgis EM, Lairson DR.

Oral Oncol. 2019 Sep;96:21-26. doi: 10.1016/j.oraloncology.2019.06.033. Epub 2019 Jul 4.


Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma.

Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME.

Thyroid. 2019 Aug;29(8):1036-1043. doi: 10.1089/thy.2019.0133.


Cost of treating recurrent respiratory papillomavirus in commercially insured and medicaid patients.

Tam S, Wu CF, Peng HL, Dahlstrom KR, Sturgis EM, Lairson DR.

Laryngoscope. 2019 Jun 13. doi: 10.1002/lary.28139. [Epub ahead of print]


Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach.

Di Credico G, Edefonti V, Polesel J, Pauli F, Torelli N, Serraino D, Negri E, Luce D, Stucker I, Matsuo K, Brennan P, Vilensky M, Fernandez L, Curado MP, Menezes A, Daudt AW, Koifman R, Wunsch-Filho V, Holcatova I, Ahrens W, Lagiou P, Simonato L, Richiardi L, Healy C, Kjaerheim K, Conway DI, Macfarlane TV, Thomson P, Agudo A, Znaor A, Boaventura Rios LF, Toporcov TN, Franceschi S, Herrero R, Muscat J, Olshan AF, Zevallos JP, La Vecchia C, Winn DM, Sturgis EM, Li G, Fabianova E, Lissowska J, Mates D, Rudnai P, Shangina O, Swiatkowska B, Moysich K, Zhang ZF, Morgenstern H, Levi F, Smith E, Lazarus P, Bosetti C, Garavello W, Kelsey K, McClean M, Ramroth H, Chen C, Schwartz SM, Vaughan TL, Zheng T, Menvielle G, Boccia S, Cadoni G, Hayes RB, Purdue M, Gillison M, Schantz S, Yu GP, Brenner H, D'Souza G, Gross ND, Chuang SC, Boffetta P, Hashibe M, Lee YA, Dal Maso L.

Oral Oncol. 2019 Jul;94:47-57. doi: 10.1016/j.oraloncology.2019.05.006. Epub 2019 May 17.


Projected oropharyngeal carcinoma incidence among middle-aged US men.

Xu L, Dahlstrom KR, Lairson DR, Sturgis EM.

Head Neck. 2019 Sep;41(9):3226-3234. doi: 10.1002/hed.25810. Epub 2019 May 24.


Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study.

Fokom Domgue J, Messick C, Milbourne A, Guo M, Salcedo MP, Dahlstrom KR, Chiao EY, Deshmukh AA, Sturgis EM, Schmeler KM.

Gynecol Oncol. 2019 May;153(2):266-270. doi: 10.1016/j.ygyno.2019.02.024. Epub 2019 Mar 1.


Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.

Koyfman SA, Ismaila N, Crook D, D'Cruz A, Rodriguez CP, Sher DJ, Silbermins D, Sturgis EM, Tsue TT, Weiss J, Yom SS, Holsinger FC.

J Clin Oncol. 2019 Jul 10;37(20):1753-1774. doi: 10.1200/JCO.18.01921. Epub 2019 Feb 27.


Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.

Ng SP, Pollard C 3rd, Berends J, Ayoub Z, Kamal M, Garden AS, Bahig H, Cantor SB, Schaefer AJ, Ajayi T, Gunn GB, Frank SJ, Skinner H, Phan J, Morrison WH, Ferrarotto R, Johnson JM, Mohamed ASR, Lai SY, Hessel AC, Sturgis EM, Weber RS, Fuller CD, Rosenthal DI.

Cancer. 2019 Jun 1;125(11):1823-1829. doi: 10.1002/cncr.31983. Epub 2019 Feb 12.


Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy.

Luo X, Sturgis EM, Yang Z, Sun Y, Wei P, Liu Z, Wei Q, Li G.

Carcinogenesis. 2019 Jul 6;40(6):735-741. doi: 10.1093/carcin/bgz019.


Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.

Lin TA, Garden AS, Elhalawani H, Elgohari B, Jethanandani A, Ng SP, Mohamed AS, Frank SJ, Glisson BS, Debnam JM, Sturgis EM, Phan J, Reddy JP, Fuller CD, Morrison WH, Skinner HD, Rosenthal DI, Gunn GB.

Cancer. 2019 May 1;125(9):1536-1546. doi: 10.1002/cncr.31944. Epub 2019 Jan 8.


Ending 40 years of silence: Rationale for a new staging system for soft tissue sarcoma of the head and neck.

Hahn E, Huang SH, Hosni A, Razak AA, Jones RL, Dickson BC, Sturgis EM, Patel SG, O'Sullivan B.

Clin Transl Radiat Oncol. 2018 Nov 27;15:13-19. doi: 10.1016/j.ctro.2018.11.009. eCollection 2019 Feb. Review.


Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT.

Lancet. 2019 Jan 5;393(10166):40-50. doi: 10.1016/S0140-6736(18)32779-X. Epub 2018 Nov 15.


Myofibrosarcoma Mimicking a Vascular Thrombosis: A Case Report.

Said RB, Williams MD, Edeiken-Monroe BS, Fornage BD, Sturgis EM, Debnam JM.

Ultrasound Int Open. 2018 Oct;4(4):E136-E138. doi: 10.1055/a-0752-9715. Epub 2018 Oct 25. No abstract available.


Reply to "Letter to the Editor in response to the article, 'The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis'".

Tam S, Fu S, Xu L, Krause K, Lairson DR, Miao H, Sturgis EM, Dahlstrom KR.

Oral Oncol. 2018 Nov;86:307. doi: 10.1016/j.oraloncology.2018.10.002. Epub 2018 Oct 9. No abstract available.


Age-Structured Population Modeling of HPV-related Cervical Cancer in Texas and US.

Peng HL, Tam S, Xu L, Dahlstrom KR, Wu CF, Fu S, Zhong C, Chan W, Sturgis EM, Ramondetta L, Rong L, Lairson DR, Miao H.

Sci Rep. 2018 Sep 25;8(1):14346. doi: 10.1038/s41598-018-32566-0.


Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.

Mak LY, Cruz-Ramón V, Chinchilla-López P, Torres HA, LoConte NK, Rice JP, Foxhall LE, Sturgis EM, Merrill JK, Bailey HH, Méndez-Sánchez N, Yuen MF, Hwang JP.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:262-279. doi: 10.1200/EDBK_200939. Review.


Incorporation of Cervista Human Papillomavirus 16/18 Assay Into Algorithms for Classifying Human Papillomavirus Status in Formalin-Fixed, Paraffin-Embedded Head and Neck Squamous Carcinoma Specimens.

Guo M, Khanna A, Wang J, Williams MD, Kalhor N, Gong Y, Xu L, Sturgis EM, Staerkel G.

Arch Pathol Lab Med. 2019 Mar;143(3):356-361. doi: 10.5858/arpa.2017-0469-OA. Epub 2018 Sep 17.


Supplemental Content

Loading ...
Support Center